10-Q: Altria Group Reports First Quarter 2024 Results, Impacted by ABI Transaction and Market Shifts

Altria's first quarter 2024 results show a mix of gains from strategic transactions and challenges from market trends, including a decline in cigarette volumes and growth in smoke-free alternatives.

Summary

• Altria's net revenues decreased by 2.5% to $5.576 billion in the first quarter of 2024, primarily due to lower smokeable product revenues.
• The company's net earnings increased by 19.1% to $2.129 billion, or $1.21 per share, driven by gains from investments and tax benefits.
• Adjusted net earnings decreased by 4.5% to $2.022 billion, or $1.15 per share, due to lower operating income.
• Domestic cigarette industry volume declined by an estimated 9%, with Altria's cigarette shipment volume down 10%.
• The oral tobacco category saw growth, with nicotine pouches now representing 40.1% of the category, while traditional smokeless tobacco declined.
• Altria completed the sale of a portion of its investment in Anheuser-Busch InBev (ABI), generating approximately $2.4 billion in pre-tax cash proceeds.
• The company repurchased $2.4 billion of its common stock through accelerated share repurchase (ASR) agreements.
• Altria's total long-term debt was $25.0 billion at the end of the quarter.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While there are positive aspects like the strategic sale of ABI shares and share repurchases, the decline in cigarette volumes and adjusted earnings, along with ongoing regulatory and litigation risks, temper the overall sentiment. The company is navigating a challenging transition period.

Positives

• Altria's net earnings saw a significant increase due to strategic transactions and tax benefits.
• The company successfully executed a share repurchase program, reducing the number of outstanding shares.
• Altria is seeing growth in the smoke-free category, particularly with nicotine pouches.
• NJOY's e-vapor market share is showing positive growth.
• The company is actively managing its debt and liquidity.

Negatives

• Altria's net revenues decreased by 2.5% due to lower smokeable product revenues.
• Adjusted net earnings and adjusted diluted EPS decreased due to lower operating income.
• Domestic cigarette industry volume declined by an estimated 9%, impacting Altria's cigarette shipment volume.
• Traditional smokeless tobacco products are experiencing a decline in market share.
• The company is facing challenges from the growth of illegal disposable e-vapor products.

Risks

• The company faces ongoing litigation and regulatory challenges, including potential product standards from the FDA.
• Macroeconomic pressures, including inflation, are impacting adult tobacco consumer spending and purchasing behavior.
• The growth of illicit trade in tobacco products, particularly e-vapor, poses a risk to the company's sales and market share.
• Changes in consumer preferences and the shift towards smoke-free alternatives could impact the value of traditional tobacco assets.
• The company is exposed to risks related to the price, availability, and quality of tobacco and other raw materials.

Future Outlook

Altria is focused on its 2028 Enterprise Goals, which include delivering mid-single-digit adjusted diluted EPS growth, a progressive dividend, and growing its U.S. smoke-free business. The company expects discretionary income pressures to continue to influence adult tobacco consumer purchase behaviors in 2024.

Management Comments

• Our Vision is to responsibly lead the transition of adult smokers to a smoke-free future.
• We are Moving Beyond Smoking, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices.
• We expect cigarette industry volume trends for the remainder of 2024 to be most influenced by (i) continued macroeconomic and discretionary income pressures on adult tobacco consumers (including inflation, interest rates, gasoline prices and unemployment levels), (ii) cross-category movement, including to illegal e-vapor products, and (iii) regulatory and legislative (including excise tax) developments.

Industry Context

The announcement reflects the ongoing shift in the tobacco industry towards smoke-free alternatives, with Altria actively investing in and expanding its presence in this space. The company is also navigating challenges from regulatory pressures, illicit trade, and changing consumer preferences, which are impacting traditional cigarette sales.

Comparison to Industry Standards

• Altria's cigarette volume decline of 10% is in line with the estimated 9% decline in the overall domestic cigarette industry, indicating that the company is facing similar headwinds as its competitors.
• The growth of Altria's nicotine pouch brand, on!, to 7.1% of the total oral tobacco category, while positive, is still behind the overall nicotine pouch category growth to 40.1%, suggesting that competitors may be gaining market share in this segment.
• The company's investment in NJOY and its 4.3% e-vapor market share indicates a strategic move to compete with other e-vapor companies, but it is still a relatively small player compared to the overall e-vapor market.
• The sale of a portion of its ABI stake and the subsequent share repurchase program is a strategic move to return capital to shareholders, similar to actions taken by other large consumer goods companies.
• Altria's focus on smoke-free products aligns with the broader industry trend of diversifying away from traditional cigarettes, as seen in the strategies of companies like Philip Morris International and British American Tobacco.

Legal Proceedings

• Altria and its subsidiaries are involved in numerous legal proceedings, including product liability, unfair trade practices, antitrust, and patent infringement cases.
• The company is also facing litigation related to its former investment in JUUL.
• PM USA has posted appeal bonds totaling approximately $38 million to obtain stays of judgments pending appeal.

Stakeholder Impact

• Shareholders will see the impact of the share repurchase program and dividend payments.
• Employees may be affected by the company's strategic shifts and cost management efforts.
• Customers will see changes in product offerings and pricing.
• Suppliers may be impacted by changes in demand for traditional tobacco products.
• Creditors are exposed to the company's debt levels and financial performance.

Next Steps

• Altria will continue to monitor the evolving macroeconomic and geopolitical landscapes.
• The company will continue to work to mitigate the potential negative impacts of these macroeconomic and geopolitical dynamics on our businesses.
• Altria will continue to evaluate the potential impacts on our business, investments and Vision as trends and developments evolve and new ones emerge.
• The company expects final settlement of the ASR transactions by June 30, 2024.

Key Dates

Keywords

Altria, tobacco, cigarettes, smoke-free, nicotine pouches, e-vapor, NJOY, ABI, share repurchase, FDA, regulation, litigation, financial results, market share, shipment volume